| Ubukho: | |
|---|---|
Igama lemveliso |
iDermal Filler |
Uhlobo |
50mL/ibhodlela |
Izithako eziphambili |
25 mg / ml Cross-linked Sodium Hyaluronate 3 mg / ml Lidocaine Hydrochloride |
Ubunzulu beSitofu |
I-dermis enzulu okanye i-subcutaneous |
Iindawo zokutofa |
Isifuba (isifuba) kunye neempundu (ummandla we-gluteal) -ukwandisa umthamo wezicubu ezithambileyo |
| Ubungakanani beNcam | Idosi yesitofu yokuQala: Ithamo lokutofa elongezelelweyo: |
Ubude bexesha |
12-24 Iinyanga |
| Beka ubomi kwishelufa | Iminyaka emi-3 |
I-Bodyfill Vial 50ml yi-CE & FDA eqinisekisiwe kabini kwaye iveliswe kwiworkshop ye-GMP yenqanaba le-100 idibana nemigangatho ye-6 ye-Sigma. I-ISO 13485 iqinisekisa ulawulo olupheleleyo lomgangatho wobomi kunye nenqanaba lesiphene elingaphantsi kwe-0.03%. Iqinisekiswe ngokuzimeleyo yi-SGS ngovavanyo lweengcali ezingama-46 ezibandakanya uhlalutyo lwe-infrared kunye ne-in-vivo degradation simulations. Uqinisekiso lwedatha yokhuseleko lwe-MSDS lubonelela ngesikhokelo esipheleleyo sosetyenziso.


I-AOMA Bodyfill Vial 50ml Dermal Filler yenzelwe ngokukodwa ukuqingqwa komzimba. Umsebenzi wayo ophambili kukuphakamisa ngobumnene kunye ne-contour, ukuphucula ukugcwala kunye nokugudiswa kwemigca ngaphandle kokugqithisa ngokugqithiseleyo, ukudala imilo ejikelezileyo kunye neqinile kunye nemiphumo ehlala iinyanga ezili-12-18. Ukuqwalaselwa kweklinikhi kubonisa ukuvakalelwa okuthambileyo kunye nezinga le-98% lokudibanisa kunye nezicubu ezijikelezayo, ngaphandle kweengxelo zokuqina.

Yintoni umzalisi womzimba kwaye yahluke njani kwifayili yobuso?
Izihluzi zomzimba zii-HA gels zomthamo omkhulu weempundu kunye namabele, ezinoxinzelelo oluphezulu lokuxhumanisa kunezahluli zobuso ukumelana noxinzelelo olunzulu lwezicubu kunye nokubonelela ngevolumu ehlala ixesha elide.
Ingaba i-body filler ihlala ixesha elingakanani?
I-AOMA Bodyfill Vial 50ml ingahlala kwiinyanga ezili-12 ukuya kwezi-24. Ubomi obude buxhomekeke kwitekhnoloji yokudibanisa umnqamlezo, ubunzulu benaliti, kunye nemetabolism yomntu ngamnye.
Ngaba inkqubo yokutofa ibuhlungu?
Nge-lidocaine esele ixutywe ngaphambili kwi-filler kunye ne-anesthetic ye-topical esetyenziswe ngaphambili, izigulane zifumana uxinzelelo okanye ukunyanzeliswa okuncinci ngexesha le-30-60 yenkqubo yemizuzu, engadingi i-anesthesia jikelele.
Ngaba isigcwalisi somzimba sinokunyibilika ukuba andizithandi iziphumo?
Ewe. Izihluzi zomzimba zibuyiselwa umva nge-hyaluronidase, eqhekeza ngokukhuselekileyo i-HA. Oku kwenza ukuba izigcwalisi zomzimba zibe lukhetho oluphantsi lokuzibophelela ngaphezu kofakelo lotyando okanye izigcwalisi ezisisigxina.
Zeziphi izatifikethi ekufuneka ndizijonge kwisigcwalisi somzimba esisemgangathweni?
Khangela i-CE & FDA isatifikethi, i-ISO 13485 yolawulo lomgangatho, uvavanyo lomntu wesithathu we-SGS, kunye namaxwebhu okhuseleko lwe-MSDS. Oku kuqinisekisa ukuba imveliso ihlangabezana nemigangatho yokhuseleko kunye nokusebenza kakuhle kwehlabathi.
| Igama leMveliso | lweDermal Filler |
|---|---|
| Uhlobo | I-50mL / i-vial |
| Izithako eziphambili | I-25 mg/ml i-Cross-linked Sodium Hyaluronate 3 mg/ml Ubunzulu beLidocaine Hydrochloride |
| Isitofu | I-dermis enzulu okanye i-subcutaneous |
| Injection Areas | Isifuba (isifuba) kunye neempundu (ummandla wegluteal) -ukwandisa umthamo |
| wezicubu ezithambileyo | I-Dose ye-Injection yokuqala: Isifuba se-Unilateral: ≤50mL; I-buttock ye-Unilateral: ≤100mL I-Top-up Injection Dose: Isifuba esisecaleni: ≤20mL; Impundu esecaleni: ≤30mL |
| Ubude bexesha | Iinyanga ze-12-24 |
| zokupakisha | I-1 PCS/IBOKSI Okanye eyenzelwe wena |
| Ubuncinci boMyalelo woMyinge | I-MOQ iqala kwiiyunithi ezingama-200. |
|---|---|
| Ukupakisha okusemgangathweni | 1 PCS / IBHOKISI Okanye eyenzelwe |
| iOEM / ileyibhile yaBucala | Ilogo, ifomula, umthamo kunye nokupakishwa ngokwezifiso ezikhoyo kwi-OEM / iiodolo zelebula yabucala. |
| Iziqinisekiso | I-AOMA ibambe i-CE, i-ISO 13485, i-GMP kunye nezatifikethi ze-FDA. Amaxwebhu ayafumaneka xa uwacela. |
| Indlela Yokuodola | Cofa i-INQUIRY NGOKU okanye uqhagamshelane nathi nge-WhatsApp okanye i-imeyile ngemveliso, ubuninzi kunye nelizwe ekusingwa kulo. |
| neMiyalelo yesitokhwe yokuThumela | Iiodolo zesitokhwe ngenqanawa phakathi kweeyure ezingama-24. |
|---|---|
| OEM / Custom Orders | Iiveki ezi-2-3 emva kokuba wonke umsebenzi wobugcisa, ifomula, kunye neenkcukacha zokupakishwa ziqinisekisiwe. |
| Ukuhambisa ngenqanawe | International Express: DHL / FedEx / UPS. |
![]() Uyilo lweLogo |
Uyilo lweLogo kwiiAmpoules |
Uyilo lweLogo kwiBhokisi yeMveliso |
Uyilo lweLogo kwiDermal Filler Packaging |
Uyilo lweLogo kwiiVials |
Uyilo lweLogo kwiLeyibhile yeDermal Filler |
![]() +III Collagen |
![]() + Lidocaine |
+PDN |
+PLLA |
+Semaglutide |
+Semaglutide |
![]() Ii-ampoules |
Ii-ampoules |
BD 1ml 2ml 10ml 20ml iisirinji |
Iingqayi |
Ukupakishwa Customization |
![]() Ukupakishwa Customization |
Ukupakishwa Customization |
Ukupakishwa Customization |
Ukupakishwa Customization |
Ukupakishwa Customization |
Ukutshintsha ukusuka kwi-Saxenda (liraglutide, imihla ngemihla) ukuya kwi-Wegovy (semaglutide, ngeveki) kuqhelekile kwizigulane ezifuna ukulahleka kwesisindo esikhulu okanye ii-injection ezimbalwa. Ngokusekelwe kwiileyibhile ezisemthethweni zase-US kunye nesikhokelo esipapashiweyo, esi sikhokelo sichaza ukuba kutheni izigulane zitshintsha, zithelekisa iishedyuli ze-dosing, kwaye zichaza inyathelo lenguqu ngesinyathelo: akukho mfuneko yokuhlamba, i-Wegovy inokuqala ukuqala ngosuku emva kwe-dose yokugqibela ye-Saxenda, i-dose yokuqala ngokuqhelekileyo i-0.25 mg (0.5 mg ithathwa njenge-off-ilebula kwezinye izigulane ezizinzile kwiiveki ze-3 mg), kunye ne-4 mg Ikwabandakanya iziphumo ebezingalindelekanga ze-GI, INYATHELO 8 iziphumo zolingo, iimpazamo eziqhelekileyo kunye nokuba ithetha ukuthini intsingiselo ye-GLP-1 kwiiklinikhi zobuhle kunye nabasasazi.
Jonga NgakumbiI-Tranexamic acid (TXA) i-mesotherapy iye yaba lukhetho lokuhamba kwiikliniki ezinyanga i-melasma enenkani. Esi sikhokelo sichaza indlela i-TXA ephazamisa ngayo isignali ye-plasmin eqhuba imveliso ye-pigment, yintoni epapashiweyo yophando lwezonyango olubonisa (Lee 2006; Budamakuntla 2013), indlela eqhelekileyo ye-TXA protocol ye-intradermal eqhutywa ngayo, esebenzayo ekhanyayo idibanisa kakuhle, iingqwalasela ezingundoqo zokhuseleko, kunye noluhlu lokukhangela lokukhangela abasasazi kunye ne-TXA brand brand yabucala ekhangela i-brendi yekliniki.
Jonga NgakumbiHlangana ne-AOMA
Udidi lweMveliso
Iiblogi